Periodically, the U.S. Food and Drug Administration (FDA) publishes guidance to industry on various matters under its regulatory jurisdiction. Typically, the agency would publish a draft copy and request input from the American public during a specific period. Upon the expiration of the comments period, the agency publishes a final version of the guidance, which [...]
Filed under: FDA, FDA Guidance, Industry Guidance | Tagged: clinical investigations, clinical research, Clinical trial, Food & Drug Administration, Institutional review board, institutional review boards, IRB, Title 21 of the Code of Federal Regulations | 1 Comment »










